ClinicaliQ Trial Snapshot
- Neurovascular Product Surveillance Registry — Recruiting • Cardiology / Cardiovascular • NCT02988128.
- What is being tested: This is a post-market surveillance registry monitoring the safety and performance of neurovascular products already in clinical use, rather than testing a new intervention in a controlled trial setting.
- Patient eligibility overview: The registry likely includes patients who have received neurovascular devices or treatments (such as stents, coils, or thrombectomy devices) for conditions like stroke, aneurysm, or other cerebrovascular disease, though specific criteria depend on individual registry protocols.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Post market surveillance registry
Eligibility Snapshot
- For MDT16056 and MDT17077 Inclusion Criteria: * Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements * Patient has, or is intended to receive or be treated with, an eligible Medtronic product * Patient is consented within the enrollment window of the therapy received, as applicable * Patient is at least 18 years of age at time of enrollment.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.